Deep Learning-Enabled Assessment of Right Ventricular Function Improves Prognostication
After Transcatheter Edge-to-Edge Repair for Mitral Regurgitation
(TKP2021-NVA-12) Funder: Ministry for Innovation and Technology
(ÚNKP-23-4-II-SE-39)
(FK 142573) Funder: NRDIO
Subjects:
Cardiovascular system
BACKGROUND: Right ventricular (RV) function has a well-established prognostic role
in patients with severe mitral regurgitation (MR) undergoing transcatheter edge-to-edge
repair (TEER) and is typically assessed using echocardiography-measured tricuspid
annular plane systolic excursion. Recently, a deep learning model has been proposed
that accurately predicts RV ejection fraction (RVEF) from 2-dimensional echocardiographic
videos, with similar diagnostic accuracy as 3-dimensional imaging. This study aimed
to evaluate the prognostic value of the deep learning-predicted RVEF values in patients
with severe MR undergoing TEER. METHODS: This multicenter registry study analyzed
the associations between the predicted RVEF values and 1-year mortality in patients
with severe MR undergoing TEER. To predict RVEF, 2-dimensional apical 4-chamber view
videos from preprocedural transthoracic echocardiographic studies were exported and
processed by a rigorously validated deep learning model. RESULTS: Good-quality 2-dimensional
apical 4-chamber view videos could be retrieved for 1154 patients undergoing TEER
between 2017 and 2023. Survival at 1 year after TEER was 84.7%. The predicted RVEF
values ranged from 26.6% to 64.0% and correlated only modestly with tricuspid annular
plane systolic excursion (Pearson R=0.33; P<0.001). Importantly, predicted RVEF was
superior to tricuspid annular plane systolic excursion levels in predicting 1-year
mortality after TEER (area under the curve, 0.687 versus 0.625; P=0.029). Furthermore,
Kaplan-Meier survival analysis revealed that patients with reduced RV function (n=723;
defined as a predicted RVEF of <45%) had significantly worse 1-year survival rates
than patients with preserved RV function (n=431; defined as a predicted RVEF of >=
45%; 80.3% [95% CI, 77.4%-83.3%] versus 92.1% [95% CI, 89.5%-94.7%]; hazard ratio
for 1-year mortality, 2.67 [95% CI, 1.82-3.90]; P<0.001). CONCLUSIONS: Deep learning-enabled
assessment of RV function using standard 2-dimensional echocardiographic videos can
refine the prognostication of patients with severe MR undergoing TEER. Thus, it can
be used to screen for patients with RV dysfunction who might benefit from intensified
follow-up care.